1Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.Lancet, 2004,363 (9407):417.
2Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.Lancet, 2004,364(9433):527.
3National CJD Surveillance Unit. CJD Statistics. Available at http://www, cjd. ed. ac. uk/figures, htm.
4Joint WHO/FAO/OIE Technical Consultation on BSE, public health, animal health and trade. Paris. June 2001. Available at www. who. int/csr/resources/publications/bse.
5FDA. Guidance for industry: revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products. Rockville:FDA. Center for Biologics Evaluation and Research. January 2002.
6Brown P, Cervendkovd L, McShane LM, et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion,1999,39(11-12):1169.
7Houston F, Foster JD, Chong A, et al. Transmission of BSE by blood transfusion in sheep. Lancet,2000,356(9234):999.
8Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol, 2002,83(11):2897.
9Hewitt PE. VCJD and blood transfusion, How real is the risk? Joint ASH and AABB Educational Session. Hematology (Am Soc Hematol Educ Program), 2004,457.
10Brown P, Cervenakova L. The modern landscape of transfusionrelated iatrogenic Creutzfeldt-Jakob disease and blood screening tests. Curr Opin Hematol,2004,11(5):351.
2National CJD Surveillace Unit.CJD Statisics.Availabie at http://www.cjd.ed.ac.uk/figures htm.
3Llewelyn CA,Hewitt PE,knight RS,et al.Possible transmision of variant Creutzfeldt-Jakob diaease by blood transfusion.Lancet,2004,363(9407):417-421.
4Peden AH,Head MW,Ritchie DL,et al.Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.Lancet,2004,364(9433):527-536.
5Health protection Agency,New Case of Variant CJD Associated with Blood Transfusion.2006 Available from URL:http://www.hpa.org.uk/pha/news/articles/press-releases/2006/060209-cjd.hitm 6A.D.
8Peter R,Foste R,Brenda D,et al.Studies on the removal of abnormal prion Protein by processes used in the manufacture of human plasma.Vox Sang,2000,78(1):86-95.
9Baron TG,Biacabe AG.Molecular analysis of the abnomal prion protein doring coinfection of mice by bovine sponsiform encephalopathy and a scrapie agent.J Virol,2001,75(1):107-114.
10FDA Guidance for industry:rerised preventive measures to reduce the possible risk of transmission of CJD and vCJD by blood and blood products Rockville:FDA Center for Biologics Evaluation and Research.2002.
